Home > Insider Trading > Nektar Therapeutics

Nektar Therapeutics (NKTR)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

1 - 10
Next >>

Nektar Therapeutics (NASDAQ:NKTR) Q3 2024 Earnings Call Transcript

Operator: Good day and thank you for standing by. Welcome to the Nektar Therapeutics' Third Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode.

Keep Reading →

November 9th, 2024 - News Transcripts

Nektar Therapeutics (NASDAQ:NKTR) Q1 2024 Earnings Call Transcript

Operator: Good day, and thank you for standing by. Welcome to the Nektar Therapeutics First Quarter 2024 Financial Results Conference Call. [Operator Instructions].

Keep Reading →

May 10th, 2024 - News Transcripts

Nektar Therapeutics (NASDAQ:NKTR) Q4 2023 Earnings Call Transcript

Nektar Therapeutics misses on earnings expectations. Reported EPS is $-0.22 EPS, expectations were $-0.2.

Keep Reading →

March 5th, 2024 - News Transcripts

Nektar Therapeutics (NASDAQ:NKTR) Q3 2023 Earnings Call Transcript

Operator: Good day and thank you for standing by. Welcome to the Nektar Therapeutics Third Quarter 2023 Financial Results Conference Call.

Keep Reading →

November 9th, 2023 - News Transcripts

12 Best Penny Stocks to Buy Under $1

Investors are optimistic as we move into the third quarter earnings season.

Keep Reading →

October 23rd, 2023 - Hedge Funds News

Nektar Therapeutics (NASDAQ:NKTR) Q2 2023 Earnings Call Transcript

Operator: Good day and thank you for standing by. Welcome to the Nektar Therapeutics Second Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.

Keep Reading →

August 10th, 2023 - News Transcripts